MeSH D027724 - assisted reproductive techniques
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D012099:Reproductive techniques
0 Companies
0 Drugs
Success rate
D027724:
Assisted reproductive techniques
D004624:Embryo transfer
0 Companies
0 Drugs
Success rate
D005307:Fertilization in vitro
0 Companies
0 Drugs
Success rate
D007315:Artificial insemination
0 Companies
0 Drugs
Success rate
D010062:Ovulation induction
D018587:Oocyte donation
0 Companies
0 Drugs
Success rate
D054315:Oocyte retrieval
0 Companies
0 Drugs
Success rate
D059247:Fertility preservation
0 Companies
0 Drugs
Success rate
D059471:In vitro oocyte maturation techniques
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Gedeon Richter | Ganirelix | Ganirelix Gedeon Richter | 2022-07-15 | |||
| Merck & Co | Follitropin alfa | Gonal-f | 1995-10-20 | |||
| Choriogonadotropin alfa | Ovitrelle | 2001-02-02 | ||||
| Organon | Ganirelix | Orgalutran | 2000-05-16 | $125 M | Q3/22-Q2/23 |
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
0%0/0
Phase 3
81%13/16
Approved: 6Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use